HomeDilutionPromotionUplist RadarBuzzToday on EDGARDead Stock Check
PubCo Insight › Tickers › CMPS

$CMPSNASDAQ NMS - GLOBAL MARKET

COMPASS Pathways plc
Biotechnology
Market Cap
$1.55B
Exchange
NASDAQ NMS - GLOBAL MARKET
Filings (365d)
20
News (14d)
5
CIK
0001816590
Website
Company site ↗
SEC Filing Timeline
8-KAug 05, 2026
Earnings release · Items 2.02,9.01
10-QAug 05, 2026
Quarterly report
8-KJul 07, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KMay 28, 2026
Shareholder vote results · Items 5.07
8-KMay 13, 2026
Earnings release · Items 2.02,9.01
10-QMay 13, 2026
Quarterly report
Recent News (Finnhub)
Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances
Yahoo · Oct 21
Compass Pathways: Built The FDA's Way, Valued At 0.57x Spravato's Sales
SeekingAlpha · Oct 21
COMPASS Pathways (CMPS) Stock May Trade At A Premium After Positive Phase 3 Results
Yahoo · Oct 18
Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (…
Yahoo · Oct 14
Definium Therapeutics: Outstanding Phase III Data De-Risks Pipeline, But Patience Required Ahead Of 2027
SeekingAlpha · Oct 13
Source-linked from SEC EDGAR + Finnhub aggregated news.
Not investment advice. Always verify on SEC.gov directly.
Investor relations · CMPS
Is this how AI describes COMPASS Pathways plc?
This page is the public, source-linked snapshot that investors, brokers, and AI assistants pull for CMPS: EDGAR filings and recent news, no editor, no spin. When an AI engine or a financial terminal shows stale, misclassified, or missing data for your ticker, that is the first thing investors see. Pulse IR runs a free 24-hour audit of how ChatGPT, Perplexity, Google, and the major terminals currently represent CMPS, and can correct it.
Get the free AI visibility audit
For company management and investor relations. Pulse IR is the investor-relations firm behind PubCo Insight.
PubCo Insight

See the dilution and promotion flags before you see the pitch.

Each week: the micro and small-caps now showing dilution or paid-promotion signals, with the SEC filing behind every flag. No recommendations, no price targets.

Every flag links to its EDGAR filing so you can check it yourself. Sponsored coverage disclosed under SEC 17(b). One-click unsubscribe.